Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 44 Squamous Cell Carcinoma of Head and Neck 22 Head and Neck Neoplasms 21 Rectal Neoplasms 17 Colonic Neoplasms 15 Neoplasm Metastasis 13 Neoplasms 12 Carcinoma, Squamous Cell 10 Carcinoma, Non-Small-Cell Lung 10 Recurrence 5 Pancreatic Neoplasms 5 Esophageal Neoplasms 4 Mouth Neoplasms 3 Lung Neoplasms 3 Laryngeal Neoplasms 3 Laryngeal Diseases 3 Breast Neoplasms 3 Tongue Neoplasms 2 Stomach Neoplasms 2 Sarcoma 2 Pharyngeal Neoplasms 2 Ovarian Neoplasms 2 Oropharyngeal Neoplasms 2 Neoplasms, Squamous Cell 2 Hereditary Sensory and Autonomic Neuropathies 2 Glioma 2 Glioblastoma 2 Colorectal Cancer Metastatic 2 Adenocarcinoma of Lung 2 Adenocarcinoma Of Esophagus 2

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Resectable Esophageal Cancer × Cetuximab × Clear all

NCT00827671 2018-03-09

TRACC

UMC Utrecht

Phase 2 Terminated

Gastrointestinal

Resectable Esophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡